New Strategies for the Treatment of Phenylketonuria (PKU)

Strisciuglio, P; Concolino, D

HERO ID

2821387

Reference Type

Journal Article

Subtype

Review

Year

2014

Language

English

PMID

25375236

HERO ID 2821387
Material Type Review
In Press No
Year 2014
Title New Strategies for the Treatment of Phenylketonuria (PKU)
Authors Strisciuglio, P; Concolino, D
Volume 4
Issue 4
Page Numbers 1007-1017
Abstract Phenylketonuria (PKU) was the first inherited metabolic disease in which dietary treatment was found to prevent the disease's clinical features. Treatment of phenylketonuria remains difficult due to progressive decrease in adherence to diet and the presence of neurocognitive defects despite therapy. This review aims to summarize the current literature on new treatment strategies. Additions to treatment include new, more palatable foods based on glycomacropeptide that contains very limited amount of aromatic amino acids, the administration of large neutral amino acids to prevent phenylalanine entry into the brain or tetrahydropterina cofactor capable of increasing residual activity of phenylalanine hydroxylase. Moreover, human trials have recently been performed with subcutaneous administration of phenylalanine ammonia-lyase, and further efforts are underway to develop an oral therapy containing phenylanine ammonia-lyase. Gene therapy also seems to be a promising approach in the near future.
Doi 10.3390/metabo4041007
Pmid 25375236
Is Certified Translation No
Dupe Override No
Comments Journal: Metabolites ISSN: 2218-1989
Is Public Yes
Language Text English